Page last updated: 2024-10-25

eflornithine and Bone Cancer

eflornithine has been researched along with Bone Cancer in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"The number and incidence of lung metastases were determined."1.33Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. ( Bond, JS; Demers, LM; DiGirolamo, DJ; Manni, A; Matters, G; Phadke, PA; Richert, MM; Washington, S; Welch, DR, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richert, MM1
Phadke, PA1
Matters, G1
DiGirolamo, DJ1
Washington, S1
Demers, LM1
Bond, JS1
Manni, A1
Welch, DR1
Ljunggren, O1
Fredholm, BB1
Lerner, UH1

Other Studies

2 other studies available for eflornithine and Bone Cancer

ArticleYear
Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
    Breast cancer research : BCR, 2005, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Eflornithine; Fe

2005
On the role of polyamines in bone resorption induced by parathyroid hormone.
    Acta physiologica Scandinavica, 1991, Volume: 142, Issue:2

    Topics: Animals; Bone Neoplasms; Bone Resorption; Calcium; Eflornithine; Mice; Ornithine Decarboxylase; Para

1991